Monoclonal gammopathy of undetermined significance and bone health outcomes: a systematic review and exploratory meta-analysis

Publication Bias

(2016) Jarrod E. Dalton et al.   ANESTHESIA AND ANALGESIA

High prevalence of secondary factors for bone fragility in patients with a recent fracture independently of BMD

(2016) F. Malgo et al.   Archives of Osteoporosis

Factors associated with an increased risk of vertebral fracture in monoclonal gammopathies of undetermined significance

(2015) J M Piot et al.   Blood Cancer Journal

Myeloma bone disease: pathogenesis, current treatments and future targets

(2014) R. E. Walker et al.   BRITISH MEDICAL BULLETIN

Unveiling Skeletal Fragility in Patients Diagnosed With MGUS: No Longer a Condition of Undetermined Significance?

(2014) Matthew T Drake   JOURNAL OF BONE AND MINERAL RESEARCH

Bone microstructural changes revealed by high-resolution peripheral quantitative computed tomography imaging and elevated DKK1 and MIP-1  levels in patients with MGUS

(2011) A. C. Ng et al.   BLOOD

Monoclonal gammopathy of undetermined significance and risk of skeletal fractures: a population-based study

(2010) S. Y. Kristinsson et al.   BLOOD

Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management

(2010) R A Kyle et al.   LEUKEMIA

The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration

(2009) Alessandro Liberati et al.   PLOS MEDICINE

Prevalence of Monoclonal Gammopathy of Undetermined Significance/Myeloma in Patients with Acute Osteoporotic Vertebral Fractures

(2008) Terry Golombick et al.   ACTA HAEMATOLOGICA